Your browser doesn't support javascript.
loading
Exhaled breath analysis in adult patients with cystic fibrosis by real-time proton mass spectrometry.
Mustafina, Malika; Silantyev, Artemiy; Krasovskiy, Stanislav; Chernyak, Alexander; Naumenko, Zhanna; Suvorov, Aleksandr; Gognieva, Daria; Abdullaev, Magomed; Bektimirova, Alina; Bykova, Aleksandra; Dergacheva, Vasilisa; Betelin, Vladimir; Kopylov, Philipp.
Afiliação
  • Mustafina M; Department of Cardiology, Functional and Ultrasound Diagnostics, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia; Pulmonology Research Institute Under Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia; Research Institute for Syste
  • Silantyev A; World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
  • Krasovskiy S; Pulmonology Research Institute Under Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.
  • Chernyak A; Pulmonology Research Institute Under Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.
  • Naumenko Z; Pulmonology Research Institute Under Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.
  • Suvorov A; World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
  • Gognieva D; World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia; Research Institute for Systemic Analysis of the Russian Academy of Sciences, 117218 Moscow, Russia.
  • Abdullaev M; World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia; Research Institute for Systemic Analysis of the Russian Academy of Sciences, 117218 Moscow, Russia.
  • Bektimirova A; World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
  • Bykova A; Department of Cardiology, Functional and Ultrasound Diagnostics, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia; Research Institute for Systemic Analysis of the Russian Academy of Sciences, 117218 Moscow, Russia.
  • Dergacheva V; World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
  • Betelin V; Research Institute for Systemic Analysis of the Russian Academy of Sciences, 117218 Moscow, Russia.
  • Kopylov P; World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia; Research Institute for Systemic Analysis of the Russian Academy of Sciences, 117218 Moscow, Russia.
Clin Chim Acta ; 560: 119733, 2024 Jun 15.
Article em En | MEDLINE | ID: mdl-38777246
ABSTRACT

BACKGROUND:

Proton-transfer reaction time-of-flight mass spectrometry (PTR-TOF-MS) is a promising tool for a rapid online determination of exhaled volatile organic compounds (eVOCs) profiles in patients with cystic fibrosis (CF).

OBJECTIVE:

To detect VOC breath signatures specific to adult patients with CF compared with controls using PTR-TOF-MS.

METHODS:

102 CF patients (54 M/48, mean age 25.6 ± 7.8 yrs) and 97 healthy controls (56 M/41F, mean age 25.8 ± 6.0 yrs) were examined. Samples from normal quiet breathing and forced expiratory maneuvers were analyzed with PTR-TOF-MS (Ionicon, Austria) to obtain VOC profiles listed as ions at various mass-to-charge ratios (m/z).

RESULTS:

PTR-TOF-MS analysis was able to detect 167 features in exhaled breath from CF patients and healthy controls. According to cluster analysis and LASSO regression, patients with CF and controls were separated. The most significant VOCs for CF were indole, phenol, dimethyl sulfide, and not indicated m/z = 297.0720 ([C12H13N2O7 and C17H13O5]H + ), m/z = 281.0534 ([C19H7NO2, C12H11NO7 and C16H9O5]H + ) during five-fold cross-validation both in forced expiratory maneuver and in normal quiet breathing.

CONCLUSION:

PTR-TOF-MS is a promising method for determining the molecular composition of exhaled air specific to CF.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espectrometria de Massas / Testes Respiratórios / Fibrose Cística / Compostos Orgânicos Voláteis Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espectrometria de Massas / Testes Respiratórios / Fibrose Cística / Compostos Orgânicos Voláteis Idioma: En Ano de publicação: 2024 Tipo de documento: Article